CyGenics Signs Collaboration Agreement with the Blood Centre of Zhejiang Province

Research license for development work on CyGenics T cells technology

24-Nov-2006 - CyGenics Ltd signed an agreement with the Blood Centre of Zhejiang Province (ZBC) in China for development work generating human T cells outside the body for the treatment of HIV, using CyGenics' proprietary cellular growth technology. This cellular growth technology is owned by CyGenics' wholly ...

CyGenics Asian Healthcare Presence Expanded in Indonesia

27-Sep-2006 - CyGenics Ltd. announced Indonesia's pharma company, Kalbe Farma, has taken a 49% stake in its cord blood banking subsidiary, CordLife Indonesia. According to the company, this is a further, important step in CyGenics strategy of focusing on its core business of tissue and cord blood banking, and ...

CyGenics Acquires Stake in DNAPro in Exchange for Cell Sciences Subsidiary

Disposes of wholly owned subsidiary, Cell Sciences, in exchange for 20% stake in DNAPro

04-Sep-2006 - CyGenics Ltd. announced that it had disposed of its wholly owned subsidiary, Cell Sciences Pte Ltd, in exchange for a 20% equity in DNAPro Sdn Bhd. Cell Sciences is primarily a distributor of various medical and research products. DNAPro is a Malaysian company engaged in manufacturing and trading ...

First Cystic Fibrosis Cord Blood Collection

Collection and storage provided free of charge by BioCell and CyGenics

28-Apr-2006 - At The Mercy Hospital in Werribee baby Aiden Brundell donated his cord blood in the hope that his stem cells could one day rejuvenate his sister Mikaela's lungs, which are failing from cystic fibrosis (CF). According to CyGenics, this first collection of cord blood from the sibling of a child ...

CyGenics Expands Into Europe

Plans to acquire stake in PharmaCell

12-Apr-2006 - CyGenics Ltd. announced its plans to establish a sound base in the European market to take advantage of exciting business opportunities in those markets. As a first step, CyGenics plans to acquire a significant stake in Dutch-based PharmaCell BV. According to the company, this investment will ...

CyGenics CEO Reappointed BioSingapore Chairman

04-Apr-2006 - CyGenics Ltd. announced that its Group CEO, Steven Fang, has been re-elected Chairman of Singapore's biotechnology industry association, BioSingapore. Mr Fang first took on the role of Chairman in October 2004, over-seeing the organisation through its early months and into its official launch ...

CyGenics awarded patent on its Cell Culture Spinner Flasks

17-Mar-2006 - CyGenics Ltd. announced that its US-based subsidiary, Cytomatrix LLC, had been granted US Patent 6991933, Cell Culture Spinner Flasks. This patent adds to the five already granted to the CyGenics group. A number of other patents are pending. The patent is for the company's unique starwheel cell ...

CyGenics in International Cancer Therapy Collaboration

International effort to develop new cancer treatment

06-Feb-2006 - CyGenics Ltd. announced that it will be part of a new international collaborative effort to develop new treatments for cancer. This will be done via the novel approach of developing and mobilising immune cells outside the human body. Called PACRIMA, the project brings together leading ...

CyGenics' Subsidiary to Distribute Bird Flu Test Kits

19-Dec-2005 - CyGenics Ltd announced that its wholly-owned subsidiary, Cell Sciences Pte Ltd, has signed an Memorandum of Understanding (MOU) with Rockeby Biomed for logistics, sales, marketing and master distribution of the Avian (bird) and Human Flu Tests for the Singapore, Malaysia, Hong Kong, Indonesia, ...

CyGenics Appoints Chief Scientific Officer

Australian scientist Associate Professor Mark Kirkland to assume position

14-Dec-2005 - CyGenics Ltd. announced the appointment of Associate Professor Mark Kirkland as its Chief Scientific Officer, with effect from 1st December 2005. Associate Professor Kirkland is a specialist haematologist , with more than 25 years experience as a medical practitioner and over 30 years' ...